Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia
University of California, Davis
University of California, Davis
Incyte Corporation
H. Lee Moffitt Cancer Center and Research Institute
Goethe University
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Zhejiang University
The First Affiliated Hospital of Soochow University
M.D. Anderson Cancer Center
Novartis
M.D. Anderson Cancer Center
Novartis
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
Masonic Cancer Center, University of Minnesota
University of Nebraska
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Medical College of Wisconsin
Medical College of Wisconsin
New York Medical College
IRCCS San Raffaele
Stanford University
Mayo Clinic
SWOG Cancer Research Network
Universität des Saarlandes
Universität des Saarlandes
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Novartis
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Pharmacyclics LLC.
Roswell Park Cancer Institute
Amgen Research (Munich) GmbH
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Maryland, Baltimore